The clonal and mutational evolution spectrum of primary triple-negative breast cancers, Nature, vol.464, pp.385-399, 2012. ,
DOI : 10.1038/nature10933
Sequence analysis of mutations and translocations across breast cancer subtypes, Nature, vol.274, issue.7403, pp.405-409, 2012. ,
DOI : 10.1038/nature11154
Whole-genome analysis informs breast cancer response to aromatase inhibition, Nature, vol.19, pp.353-360, 2012. ,
DOI : 10.1038/nature11143
A reason why the ERBB2 gene is amplified and not mutated in breast cancer, Cancer Cell International, vol.9, issue.1, p.5, 2009. ,
DOI : 10.1186/1475-2867-9-5
ErbB receptors and signaling pathways in cancer, Current Opinion in Cell Biology, vol.21, issue.2, pp.177-184, 2009. ,
DOI : 10.1016/j.ceb.2008.12.010
A human functional protein interaction network and its application to cancer data analysis, Genome Biology, vol.11, issue.5, p.53, 2010. ,
DOI : 10.1186/gb-2010-11-5-r53
Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation, Nature Reviews Genetics, vol.13, issue.2, pp.115-127, 2008. ,
DOI : 10.1038/nrg2269
Signalling, cell cycle and pluripotency in embryonic stem cells, Trends in Cell Biology, vol.12, issue.9, pp.432-438, 2002. ,
DOI : 10.1016/S0962-8924(02)02352-8
Regulation of cancer cell metabolism, Nature Reviews Cancer, vol.118, issue.2, pp.85-95, 2011. ,
DOI : 10.1038/nrc2981
FOXOs: signalling integrators for homeostasis maintenance, Nature Reviews Molecular Cell Biology, vol.14, issue.2, pp.83-97, 2013. ,
DOI : 10.1038/nrm3507
Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling, Current Cancer Drug Targets, vol.13, issue.2, pp.188-204, 2013. ,
DOI : 10.2174/1568009611313020008
Hypothesis: more mutations to cure cancer?, Oncology Reports, vol.6, pp.1189-1190, 1999. ,
DOI : 10.3892/or.6.6.1189